On Wednesday, K2’s self-evaluation was sent to the Research Council of Norway. It turned out to be a document of 268 pages. As with previous evaluations, this has taken a significant focus for the institute administration and those of you who contributed to the self-evaluation. In addition to the institute’s overall self-evaluation, the following research groups participated with their own self-evaluation:
- Bergen Respiratory Research Group by Tomas Mikal Lind Eagan
- Broegelmann by Helena Erlandsson Harris
- Endocrine Medicine by Eystein S. Husebye
- Research Group for Infection and Microbiology by Rebecca Jane Cox
- Drug Group by Lars Herfindal
- Mohn Center for Diabetes Precision Medicine by Pål R. Njølstad
- Oncology by Stian Knappskog
- Paediatric Follow-up Group by Camilla Tøndel
- Precision Oncology by Ola Myklebost
In addition, the following impact cases participated:
- Catching the rhythms by Eystein S. Husebye
- Changing clinical practice in childhood diabetes by precision medicine by Pål R. Njølstad
- Heart disease in women by Eva Gerdts
- Pandemic preparedness: the COVID-19 case by Rebecca Cox
The process ahead is a three-step evaluation. First, research groups are evaluated in expert panels categorized by field/discipline across sectors. Then, administrative units are evaluated in evaluation committees that are sector-specific. The third step is the national level, which includes all medical research in Norway. A selection of experts from the evaluation is used here.
The administrative units are the main object of the evaluation. Evaluation results for the research groups will be included in the evaluation report for the administrative unit to which they belong.
Many thanks to everyone who participated – especially Susanne and Silke – for great effort over a long period. Now we can enjoy the weekend with a clear conscience and hope for a good result!
Pål
